Natasha Hindman
Optometrist · Cranberry Twp, PANPI 1881742138
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,210 of the $4,595 with a category attached, or 69.9%. It is spread thinly across 17 manufacturers, the largest accounting for just 22.5%. Reporting peaked in 2023 at $2,123 and has fallen 56.2% since, to $930 in 2025. Among optometrist clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $47.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Glaukos Corporation$1K
- Tarsus Pharmaceuticals, Inc.$595
- Novartis$490
- Alcon Research LLC$429
- Bausch & Lomb Americas Inc.$336
- plus $682 from 11 others
Across 9 payments — averaging $19,348 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch & Lomb Americas Inc.$163K
- AbbVie$7K
- Glaukos Corporation$4K
What the payments were for
- Consulting fees$3808%
- Travel & lodging$1,00522%
- Food & beverage$3,21070%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 11 | $1,032 |
| Glaukos Corporation | 34 | $1,031 |
| Tarsus Pharmaceuticals, Inc. | 3 | $595 |
| Novartis | 10 | $490 |
| Alcon Research LLC | 1 | $429 |
| Bausch & Lomb Americas Inc. | 12 | $336 |
| AbbVie(2 entities) | 8 | $181 |
| Sight Sciences, Inc. | 3 | $145 |
| Amgen | 1 | $107 |
| Aerie Pharmaceuticals, Inc. | 4 | $66 |
| Genentech USA, Inc. | 2 | $55 |
| Sun Pharmaceutical Industries Inc. | 2 | $34 |
| Harrow Eye, LLC | 1 | $22 |
| Shire North American Group Inc | 1 | $21 |
| Oyster Point Pharma, Inc. | 1 | $18 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $18 |
| Dompe US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,595 in reported general payments places this provider in the 90th percentile of 2,165 optometrist providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 12 | $129 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Cranberry Twp
- James DeomHazle Township$793K
- Gregory CaldwellDuncansville$547K
- Leslie O DellNew Freedom$388K
- Kevin BistlinePlymouth Meeting$302K
- Thomas KislanStroudsburg$266K
- Erick HendersonPittsburgh$266K
- Ryan YealyLancaster$164K
- Joseph SmayNew Kensington$147K
- Julie McLaughlinAllentown$142K
- Robert RosenthalNewtown$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.